,outcome,arm 1,arm 2
0,intervention,TLC D-99 patients,doxorubicin patients
0,Protocol-defined cardiotoxicity was,"13 % of, 2 cases","29 % of, 9 cases, CHF )"
0,"Protocol-defined cardiotoxicity was, total study group",CHF ),CHF )
